Cargando…

Clinical application of combined laparoscopic surgery in the treatment of primary hepatocellular carcinoma with portal hypertension: a report of 16 cases

Primary hepatocellular carcinoma (HCC) is a common malignant tumor in China and is often accompanied by portal hypertension (PHT). Whether simultaneous operation can be used in patients with liver cirrhosis and PHT accompanied by HCC is controversial. The aim of the present study was to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Peng, Liao, Shengtao, Li, Jianwei, Zheng, Shuguo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2019
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797662/ https://www.ncbi.nlm.nih.gov/pubmed/35116762 http://dx.doi.org/10.21037/tcr.2019.01.23

Ejemplares similares

Minimally invasive liver surgery for hepatocellular carcinoma in patients with portal hypertension
por: Aliseda, Daniel, et al.
Publicado: (2023)

Portal hypertension and hepatocellular carcinoma: Navigating uncharted waters
por: Sidali, Sabrina, et al.
Publicado: (2022)

Laparoscopic Cholecystectomy in Patients with Bilharzial Portal Hypertension
por: Isam, Salam MA, et al.
Publicado: (2000)

Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension
por: Zhong, Jian-Hong, et al.
Publicado: (2014)

Current status of radical laparoscopy for treating hepatocellular carcinoma with portal hypertension
por: Shen, Ze-Feng, et al.
Publicado: (2021)

Liver resection for hepatocellular carcinoma in patients with clinically significant portal hypertension
por: Azoulay, Daniel, et al.
Publicado: (2020)

Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension: a case report: Splenic arteriovenous fistula leading to non-cirrhotic portal hypertension
por: Abou Yassine, Ahmad, et al.
Publicado: (2023)

Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis after Concurrent Chemoradiation Therapy
por: Han, Dai Hoon, et al.
Publicado: (2016)

The Benefits of Radical Treatments with Synchronous Splenectomy for Patients with Hepatocellular Carcinoma and Portal Hypertension
por: Zhang, Qikun, et al.
Publicado: (2022)

Long-term outcomes of laparoscopic liver resection versus open liver resection for hepatocellular carcinoma: A single-center 10-year experience
por: Tian, Feng, et al.
Publicado: (2023)

Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?
por: Barros, Andrea Zaidan de Almeida, et al.
Publicado: (2022)

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
por: Lv, Wei-Fu, et al.
Publicado: (2018)

Prevalence of gastric varices and portal hypertensive gastropathy in patients with Symmers’ periportal fibrosis
por: Mudawi, Hatim, et al.
Publicado: (2008)

Short- and long-term effects of transarterial chemoembolization on portal hypertension in patients with hepatocellular carcinoma
por: Scheiner, Bernhard, et al.
Publicado: (2019)

Portal hypertension in patients with hepatocellular carcinoma and immunotherapy: prognostic relevance of CT-morphologic estimates
por: Müller, Lukas, et al.
Publicado: (2023)

Transarterial Ethanol Ablation Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
por: Yang, Biao, et al.
Publicado: (2016)

Efficacy and Safety of 8- or 12 Weeks of Glecaprevir/Pibrentasvir in Patients with Evidence of Portal Hypertension
por: Brown, Robert S., et al.
Publicado: (2022)

Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
por: Shao, Zhiying, et al.
Publicado: (2021)

Combined hepatocellular carcinoma–cholangiocarcinoma: A misdiagnosed case preoperatively
por: Ding, Lei, et al.
Publicado: (2021)

Totally laparoscopic radiofrequency-assisted liver partition with portal vein ligation for hepatocellular carcinoma in cirrhotic liver
por: Rong, Zhixia, et al.
Publicado: (2017)

Laparoscopic Left Hepatectomy with Middle Hepatic Vein Resection for Hepatocellular Carcinoma with Extrahepatic Portal Vein Obstruction
por: Umemura, Akira, et al.
Publicado: (2021)

Advances and challenges in laparoscopic surgery in the management of hepatocellular carcinoma
por: Ziogas, Ioannis A, et al.
Publicado: (2017)

Leaping the Boundaries in Laparoscopic Liver Surgery for Hepatocellular Carcinoma
por: Cassese, Gianluca, et al.
Publicado: (2022)

Hand-assisted laparoscopic Hassab’s procedure for esophagogastric varices with portal hypertension
por: Kobayashi, Takashi, et al.
Publicado: (2017)

Laparoscopic selective esophagogastric devascularization and splenectomy for patients with cirrhotic portal hypertension
por: Lin, Jie, et al.
Publicado: (2018)

Laparoscopic distal pancreatectomy for pancreatic arteriovenous malformation complicated with portal hypertension
por: Abiko, Takehiro, et al.
Publicado: (2021)

Benefits of Splenectomy and Curative Treatments for Patients with Hepatocellular Carcinoma and Portal Hypertension: a Retrospective Study
por: Pei, Youliang, et al.
Publicado: (2018)

Sub-Classification of Cirrhosis Affects Surgical Outcomes for Early Hepatocellular Carcinoma Independent of Portal Hypertension
por: Zhang, Er-lei, et al.
Publicado: (2021)

Effects of hypersplenism on the outcome of hepatectomy in hepatocellular carcinoma with hepatitis B virus related portal hypertension
por: Chen, Xiao, et al.
Publicado: (2023)

The Role of Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Treating Portal Hypertension in Patients with Hepatocellular Carcinoma
por: Balducci, Daniele, et al.
Publicado: (2023)

Surgical approach to multifocal hepatocellular carcinoma with portal vein thrombosis and arterioportal shunt leading to portal hypertension and bleeding: a case report
por: Ratti, Francesca, et al.
Publicado: (2012)

INTRABEAM intraoperative radiotherapy combined with portal vein infusion chemotherapy for treating hepatocellular carcinoma with portal vein tumor thrombus
por: Song, Xiaodong, et al.
Publicado: (2020)

TACE combined with portal particle implantation in a case of stage IIIa primary hepatocellular carcinoma treated with sequential anlotinib
por: Lin, Cheng, et al.
Publicado: (2023)

Laparoscopic splenectomy and esophagogastric devascularization combined with fast-track principles offers greater benefit for patients with portal hypertension
por: Wang, Dong, et al.
Publicado: (2022)

Can a laparoscopic surgery be an alternative to transjugular intrahepatic portosystemic shunts (TIPS) for the treatment of portal hypertensive bleeding?
por: Huang, Bin, et al.
Publicado: (2023)

The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis
por: He, Wei, et al.
Publicado: (2015)

The preoperative platelet to albumin ratio predicts the prognosis of hepatocellular carcinoma patients without portal hypertension after liver resection
por: Li, Chuan, et al.
Publicado: (2019)

GIMAP5 maintains liver endothelial cell homeostasis and prevents portal hypertension
por: Drzewiecki, Kaela, et al.
Publicado: (2021)

Maternal and Perinatal Outcome in a Contemporary Cohort of Patients with Portal Hypertension: A Single-Center Experience
por: Kosian, Philipp, et al.
Publicado: (2023)

Hepatocellular carcinoma with portal invasion, still a place for liver surgery in the era of immunotherapy?
por: Giudicelli, Héloïse, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a6e902usf1r1thep7us5dm1p8o